Vaxxinity, Inc. (VAXX)
OTCMKTS
· Delayed Price · Currency is USD
0.0430
+0.0429 (42,900.00%)
Aug 15, 2025, 11:15 AM EDT
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $5.45 million as of August 15, 2025. Its market cap has decreased by -87.89% in one year.
Market Cap
5.45M
Enterprise Value
-10.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 5.45M, a decrease of -99.74%. That is a compound annual growth rate of -79.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 5.45M | 760.00% |
Dec 31, 2024 | 633.74K | -99.41% |
Dec 29, 2023 | 107.73M | -38.95% |
Dec 30, 2022 | 176.48M | -74.91% |
Dec 31, 2021 | 703.46M | -66.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 972.93M |
Veradigm | 781.22M |
Tian'an Technology Group | 628.15M |
Glass House Brands | 606.72M |
Elite Pharmaceuticals | 567.29M |
American Oncology Network | 389.51M |
Northwest Biotherapeutics | 351.78M |
CytoDyn | 336.73M |